Plus Therapeutics to Present at the virtual Fall Investor Summit on November 16th-18th

Rhea-AI Summary

Plus Therapeutics (NASDAQ:PSTV) is a clinical-stage pharmaceutical company focused on nanoliposome-encapsulated radionuclides targeting various cancer types, including recurrent glioblastoma. The company is set to present at the virtual Fall Investor Summit scheduled for November 16-18, 2020. This summit will feature 75 companies and engage over 300 institutional and retail investors, providing a platform for fostering connections between smallcap and microcap firms and potential investors.

NEW YORK, NY / ACCESSWIRE / November 12, 2020 / Plus Therapeutics (NASDAQ:PSTV), is a clinical-stage pharmaceutical company whose radiotherapeutic portfolio is concentrated on nanoliposome-encapsulated radionuclides for several cancer targets, including recurrent glioblastoma. PSTV will be presenting at this year's virtual Fall Investor Summit on November 16^th-18^th.

The Fall Investor Summit will take place virtually, featuring 75 companies and over 300 institutional and retail investors.

About Plus Therapeutics

Plus Therapeutics (NASDAQ:PSTV) is a clinical-stage pharmaceutical company whose radiotherapeutic portfolio is concentrated on nanoliposome-encapsulated radionuclides for several cancer targets. Central to the Company's drug development is a unique nanotechnology platform designed to reformulate, deliver and commercialize multiple drugs targeting rare cancers and other diseases. The platform is designed to facilitate new delivery approaches and/or formulations of safe and effective, injectable drugs, potentially enhancing the safety, efficacy and convenience for patients and healthcare providers. More information may be found atplustherapeutics.com andrespect-trials.com.

The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors.

To register as a presenting company: please contact Brittney Blocker (brittney@investorsummitgroup.com)

To request complimentary investor registration: please visit our website at www.investorsummitgroup.com

News Compliments of ACCESSWIRE

FOR MORE INFORMATION

Please visit: www.investorsummitgroup.com

Or, contact Brittney Blocker at brittney@investorsummitgroup.com

SOURCE: Plus Therapeutics

View source version on accesswire.com:
https://www.accesswire.com/615981/Plus-Therapeutics-to-Present-at-the-virtual-Fall-Investor-Summit-on-November-16th-18th

FAQ

What is the date of Plus Therapeutics' presentation at the Fall Investor Summit?

Plus Therapeutics will present at the Fall Investor Summit from November 16-18, 2020.

What is the focus of Plus Therapeutics' drug development?

Plus Therapeutics focuses on nanoliposome-encapsulated radionuclides for targeting several cancers, including recurrent glioblastoma.

How many companies are participating in the Fall Investor Summit?

The Fall Investor Summit features 75 companies.

Who can register for the Fall Investor Summit?

Both institutional and retail investors can register for the Fall Investor Summit.

What is the stock symbol for Plus Therapeutics?

The stock symbol for Plus Therapeutics is PSTV.